Diversified Growth Company - Medtech DPM EUR H/  LU2304351971  /

Fonds
NAV30.10.2024 Diff.+0,0500 Ertragstyp Ausrichtung Fondsgesellschaft
79,0600EUR +0,06% thesaurierend Aktien weltweit NS Partners 

Investmentstrategie

The objective is to achieve a better performance in a global equity market than the MSCI World Health Care Equipment and Supplies (USD) index by investing mainly in shares, certificates of shares and equity-like transferable securities that fall into the investment universe of the medical technology industry globally. The Sub-Fund will have a diversified portfolio exposed to global equity markets (Europe, North America, Asia and emerging markets). The Sub-Fund promotes social and environmental characteristics by investing at least 85% of its net assets in shares, certificates of shares and equity-like transferable securities with exposure to global equity markets that exhibit strong ESG credentials, with a specific focus on CO2 emissions.
 

Investmentziel

The objective is to achieve a better performance in a global equity market than the MSCI World Health Care Equipment and Supplies (USD) index by investing mainly in shares, certificates of shares and equity-like transferable securities that fall into the investment universe of the medical technology industry globally.
 

Zusatzinfotext

Dieser Fonds befindet sich in Liquidation.
 

Stammdaten

Ertragstyp: thesaurierend
Fondskategorie: Aktien
Region: weltweit
Branche: Branche Gesundheit/Pharma
Benchmark: MSCI World Health Care Equipment and Supplies (USD) index
Geschäftsjahresbeginn: 01.01
Letzte Ausschüttung: -
Depotbank: UBS Europe SE, Luxembourg Branch
Ursprungsland: Luxemburg
Vertriebszulassung: Schweiz
Fondsmanager: NS Partners SA
Fondsvolumen: 25,2 Mio.  USD
KESt-Meldefonds: -
Auflagedatum: 11.02.2022
Investmentfokus: -

Konditionen

Ausgabeaufschlag: 3,00%
Max. Verwaltungsgebühr: 1,50%
Mindestveranlagung: - EUR
Weitere Gebühren: 0,04%
Tilgungsgebühr: 0,00%
Laufende Kosten (31.12.2019): 1,90%
Wesentliche Anlegerinformation: Download (Druckversion)
 

Fondsgesellschaft

KAG: NS Partners
Adresse: 11, Boulevard de la Foire, 1528, Luxembourg
Land: Luxemburg
Internet: www.nspgroup.com/
 

Veranlagungen

Aktien
 
98,40%
Barmittel und sonstiges Vermögen
 
1,60%

Länder

Nordamerika
 
71,50%
Schweiz
 
17,20%
Europa
 
9,60%
Sonstige
 
1,70%

Branchen

Gesundheitswesen
 
98,40%
Barmittel und sonst. VM
 
1,60%